The bill proposes the enactment of new sections in the Revised Code to mandate insurance and Medicaid coverage for scalp cooling systems used by individuals undergoing cancer chemotherapy treatments. Specifically, it defines a "scalp cooling system" as a device designed to cool the human scalp to prevent or reduce hair loss during chemotherapy, emphasizing that it must be intended for repeated use and serve a medical purpose. The bill requires that all individual or group health insurance policies, as well as public employee benefit plans, that provide coverage for cancer chemotherapy must also cover the expenses associated with scalp cooling systems.

Additionally, the bill stipulates that the Medicaid program will cover scalp cooling systems for recipients undergoing chemotherapy, with the Medicaid director authorized to adopt necessary rules for implementation. This legislation aims to enhance the quality of life for cancer patients by addressing the side effects of chemotherapy, particularly hair loss, through the provision of necessary medical devices.